- Home
- HYPR vs MDAI Comparison
HYPR vs MDAI Comparison
Compare HYPR & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYPR
- MDAI
- Stock Information
- Founded
- HYPR 2014
- MDAI 2013
- Country
- HYPR United States
- MDAI United States
- Employees
- HYPR N/A
- MDAI N/A
- Industry
- HYPR Medical Specialities
- MDAI Medical/Dental Instruments
- Sector
- HYPR Health Care
- MDAI Health Care
- Exchange
- HYPR Nasdaq
- MDAI Nasdaq
- Market Cap
- HYPR 55.9M
- MDAI 69.0M
- IPO Year
- HYPR N/A
- MDAI N/A
- Fundamental
- Price
- HYPR $1.02
- MDAI $2.46
- Analyst Decision
- HYPR Strong Buy
- MDAI Strong Buy
- Analyst Count
- HYPR 3
- MDAI 2
- Target Price
- HYPR $1.06
- MDAI $4.75
- AVG Volume (30 Days)
- HYPR 487.2K
- MDAI 679.3K
- Earning Date
- HYPR 08-07-2025
- MDAI 08-12-2025
- Dividend Yield
- HYPR N/A
- MDAI N/A
- EPS Growth
- HYPR N/A
- MDAI N/A
- EPS
- HYPR N/A
- MDAI N/A
- Revenue
- HYPR $11,732,000.00
- MDAI $29,962,000.00
- Revenue This Year
- HYPR $12.31
- MDAI N/A
- Revenue Next Year
- HYPR $29.29
- MDAI $15.15
- P/E Ratio
- HYPR N/A
- MDAI N/A
- Revenue Growth
- HYPR 0.34
- MDAI 55.21
- 52 Week Low
- HYPR $0.53
- MDAI $0.82
- 52 Week High
- HYPR $1.90
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- HYPR 59.21
- MDAI 48.97
- Support Level
- HYPR $1.00
- MDAI $2.43
- Resistance Level
- HYPR $1.20
- MDAI $2.84
- Average True Range (ATR)
- HYPR 0.10
- MDAI 0.20
- MACD
- HYPR 0.01
- MDAI -0.05
- Stochastic Oscillator
- HYPR 59.09
- MDAI 16.18
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.